This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Avoid common budget mistakes by knowing what not to include in a budget. This quick intro highlights pitfalls and simple tweaks to improve your spending plan.
26,809 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
After-hours moves often reveal the next chapter for crypto firms. Gemini shares rise after hours as investors embrace...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Oxford Square Capital trades at a 24% yield, yet a steep NAV decline and Q4 losses cast doubt on earnings durability....
A California jury has ruled that Meta and YouTube were liable for harms linked to minors on their platforms, awarding...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
AMD is grabbing attention as its stock soars. This guide breaks down the core drivers, the risks, and concrete steps ...
Emerging market small caps are posting growing trailing dividends despite volatile quarterly payments, helping them b...
Mortgage purchase apps holding steady in 2026 despite rising rates, underscoring persistent demand in the housing mar...
Seeing a neighbor's Social Security check grow while yours stays the same can feel frustrating. This guide explains t...
A Two Harbors shareholder files a federal lawsuit to block the CCM merger vote, alleging deceptive proxy disclosures ...